GREENPOWER MOTOR CO INC (GP)

CA39540E3023 - Common Stock

0.82  +0.02 (+2.5%)

After market: 0.83 +0.01 (+1.22%)

Fundamental Rating

1

Overall GP gets a fundamental rating of 1 out of 10. We evaluated GP against 131 industry peers in the Machinery industry. GP may be in some trouble as it scores bad on both profitability and health. GP is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

GP had negative earnings in the past year.
In the past year GP has reported a negative cash flow from operations.
In the past 5 years GP always reported negative net income.
In the past 5 years GP always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of GP (-54.26%) is worse than 91.34% of its industry peers.
GP has a worse Return On Equity (-514.32%) than 94.49% of its industry peers.
Industry RankSector Rank
ROA -54.26%
ROE -514.32%
ROIC N/A
ROA(3y)-31.51%
ROA(5y)-30.65%
ROE(3y)-85.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 9.35%, GP is doing worse than 91.34% of the companies in the same industry.
In the last couple of years the Gross Margin of GP has declined.
The Profit Margin and Operating Margin are not available for GP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.3%
GM growth 5Y-14.89%

More info and screens

0

2. Health

2.1 Basic Checks

GP does not have a ROIC to compare to the WACC, probably because it is not profitable.
GP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GP has been increased compared to 5 years ago.
The debt/assets ratio for GP is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -2.99, we must say that GP is in the distress zone and has some risk of bankruptcy.
GP has a Altman-Z score of -2.99. This is amonst the worse of the industry: GP underperforms 89.76% of its industry peers.
A Debt/Equity ratio of 3.20 is on the high side and indicates that GP has dependencies on debt financing.
The Debt to Equity ratio of GP (3.20) is worse than 94.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Altman-Z -2.99
ROIC/WACCN/A
WACC8.13%

2.3 Liquidity

GP has a Current Ratio of 1.44. This is a normal value and indicates that GP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.44, GP is doing worse than 79.53% of the companies in the same industry.
A Quick Ratio of 0.06 indicates that GP may have some problems paying its short term obligations.
GP has a Quick ratio of 0.06. This is amonst the worse of the industry: GP underperforms 98.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.06

More info and screens

5

3. Growth

3.1 Past

GP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.61%.
The Revenue for GP has decreased by -60.11% in the past year. This is quite bad
The Revenue has been growing by 45.21% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-42.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
Revenue 1Y (TTM)-60.11%
Revenue growth 3Y43.51%
Revenue growth 5Y45.21%
Sales Q2Q%-36.64%

3.2 Future

GP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.05% yearly.
The Revenue is expected to grow by 17.68% on average over the next years. This is quite good.
EPS Next Y9.88%
EPS Next 2Y25.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-27.28%
Revenue Next 2Y23.44%
Revenue Next 3Y17.68%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GP. In the last year negative earnings were reported.
Also next year GP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

GP's earnings are expected to grow with 25.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.05%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GP!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREENPOWER MOTOR CO INC

NASDAQ:GP (1/6/2025, 5:32:34 PM)

After market: 0.83 +0.01 (+1.22%)

0.82

+0.02 (+2.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)02-11 2025-02-11/bmo
Inst Owners1.4%
Inst Owner Change0%
Ins Owners24.88%
Ins Owner ChangeN/A
Market Cap24.18M
Analysts84.44
Price Target1.23 (50%)
Short Float %0.2%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.04%
Min EPS beat(2)2.91%
Max EPS beat(2)5.17%
EPS beat(4)2
Avg EPS beat(4)-18.27%
Min EPS beat(4)-54.2%
Max EPS beat(4)5.17%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-23.54%
Min Revenue beat(2)-40.62%
Max Revenue beat(2)-6.47%
Revenue beat(4)0
Avg Revenue beat(4)-29.81%
Min Revenue beat(4)-43.83%
Max Revenue beat(4)-6.47%
Revenue beat(8)2
Avg Revenue beat(8)-16.31%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.91%
PT rev (3m)-27.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-83.33%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-67.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.12
P/FCF N/A
P/OCF N/A
P/B 5.82
P/tB 5.82
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.27
OCFYN/A
SpS0.73
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -54.26%
ROE -514.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.35%
FCFM N/A
ROA(3y)-31.51%
ROA(5y)-30.65%
ROE(3y)-85.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.3%
GM growth 5Y-14.89%
F-Score1
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 3.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.13%
Cap/Sales 1.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.06
Altman-Z -2.99
F-Score1
WACC8.13%
ROIC/WACCN/A
Cap/Depr(3y)43.23%
Cap/Depr(5y)47.66%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.88%
EPS Next Y9.88%
EPS Next 2Y25.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-60.11%
Revenue growth 3Y43.51%
Revenue growth 5Y45.21%
Sales Q2Q%-36.64%
Revenue Next Year-27.28%
Revenue Next 2Y23.44%
Revenue Next 3Y17.68%
Revenue Next 5YN/A
EBIT growth 1Y-55.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.21%
EBIT Next 3Y18.64%
EBIT Next 5YN/A
FCF growth 1Y56.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.12%
OCF growth 3YN/A
OCF growth 5YN/A